Cargando…
Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis
Hepatocellular carcinoma (HCC) is a primary cause of cancer-related death in the world. Despite the fact that there are many methods to treat HCC, the 5-year survival rate of HCC is still at a low level. Emodin can inhibit the growth of HCC cells in vitro and in vivo. However, the gene regulation of...
Autores principales: | Zhou, Rui-sheng, Wang, Xiong-Wen, Sun, Qin-feng, Ye, Zeng Jie, Liu, Jian-wei, Zhou, Dai-Han, Tang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545785/ https://www.ncbi.nlm.nih.gov/pubmed/31236404 http://dx.doi.org/10.1155/2019/3065818 |
Ejemplares similares
-
NMR-based Metabolomic Techniques Identify the Toxicity of Emodin in HepG2 Cells
por: Chen, Chang, et al.
Publicado: (2018) -
Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells
por: Jiang, Qin, et al.
Publicado: (2017) -
Sublethal hyperthermia enhances anticancer activity of doxorubicin in chronically hypoxic HepG2 cells through ROS-dependent mechanism
por: Wang, Qi, et al.
Publicado: (2021) -
Investigation of the anti-cancer effect of quercetin on HepG2 cells in vivo
por: Zhou, Jin, et al.
Publicado: (2017) -
Anticancer Effect of Rh2, a Histone Deacetylase Inhibitor, in HepG2 Cells and HepG2 Cell-Derived Xenograft Tumors Occurs via the Inhibition of HDACs and Activation of the MAPK Signaling Pathway
por: Qiang, Shi Qing, et al.
Publicado: (2021)